Michael Derby - 14 Jul 2023 Form 4 Insider Report for Acasti Pharma Inc. (GRCE)

Role
Director
Signature
/s/ Prashant Kohli, as attorney-in-fact
Issuer symbol
GRCE
Transactions as of
14 Jul 2023
Net transactions value
$0
Form type
4
Filing time
18 Jul 2023, 16:37:14 UTC
Previous filing
28 Apr 2023
Next filing
28 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +12,500 $0.000000 12,500 14 Jul 2023 Class A Common Shares 12,500 $2.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal monthly installments over a period of 12 months.

Remarks:

Exhibit 24, Power of Attorney, is attached.